In recent years, non-radioactive nucleic acid labeling and detection methodologies have become available in response to a desire by researchers and their institutions to move away from the use of radioisotopes. Advancements made in the areas of chemiluminescence and fluorescence have allowed for an easier transition. In non-radioactive assays, signal is generated through an enzymatic reaction with a chemiluminescent or chromogenic substrate; alternatively, detection can occur through the appropriate excitation and emission of a fluorophore-labeled probe.
Global Non-Radioactive Nucleic Acid Labeling Product key players include Thermo Fisher Scientific, Roche, Promega, etc. Global top three manufacturers hold a share over 40%.
United States is the largest market, with a share over 40%, followed by China
and Europe, both have a share about 35 percent.
In terms of product, DIG System is the largest segment, with a share about 33%. And in terms of application, the largest application is DNA Labeling, followed by RNA Labeling, Oligonucleotide Labeling.
The global Non-Radioactive Nucleic Acid Labeling Product market was valued at US$ 301 million in 2020 and is expected to reach US$ 510.4 million by the end of 2029, growing at a CAGR of 6.9% during 2021-2029.
This report focuses on Non-Radioactive Nucleic Acid Labeling Product volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Non-Radioactive Nucleic Acid Labeling Product market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Non-Radioactive Nucleic Acid Labeling Product Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2029. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Biotin
DIG System
Fluorescent
Others
Segment by Application
DNA Labeling
RNA Labeling
Oligonucleotide Labeling
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Thermo Fisher Scientific
Roche
Promega
PerkinElmer
Agilent Technologies
General Electric
Enzo Biochem
Merck KGaA
Vector Labs
New England Biolabs
1 Non-Radioactive Nucleic Acid Labeling Product Market Overview
1.1 Product Overview and Scope of Non-Radioactive Nucleic Acid Labeling Product
1.2 Non-Radioactive Nucleic Acid Labeling Product Segment by Type
1.2.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales Growth Rate Comparison by Type (2021-2029)
1.2.2 Biotin
1.2.3 DIG System
1.2.4 Fluorescent
1.2.5 Others
1.3 Non-Radioactive Nucleic Acid Labeling Product Segment by Application
1.3.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales Comparison by Application: (2021-2029)
1.3.2 DNA Labeling
1.3.3 RNA Labeling
1.3.4 Oligonucleotide Labeling
1.4 Global Non-Radioactive Nucleic Acid Labeling Product Market Size Estimates and Forecasts
1.4.1 Global Non-Radioactive Nucleic Acid Labeling Product Revenue 2016-2029
1.4.2 Global Non-Radioactive Nucleic Acid Labeling Product Sales 2016-2029
1.4.3 Non-Radioactive Nucleic Acid Labeling Product Market Size by Region: 2016 Versus 2021 Versus 2029
2 Non-Radioactive Nucleic Acid Labeling Product Market Competition by Manufacturers
2.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Manufacturers (2016-2021)
2.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Non-Radioactive Nucleic Acid Labeling Product Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Non-Radioactive Nucleic Acid Labeling Product Manufacturing Sites, Area Served, Product Type
2.5 Non-Radioactive Nucleic Acid Labeling Product Market Competitive Situation and Trends
2.5.1 Non-Radioactive Nucleic Acid Labeling Product Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-Radioactive Nucleic Acid Labeling Product Players Market Share by Revenue
2.5.3 Global Non-Radioactive Nucleic Acid Labeling Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Radioactive Nucleic Acid Labeling Product Retrospective Market Scenario by Region
3.1 Global Non-Radioactive Nucleic Acid Labeling Product Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Non-Radioactive Nucleic Acid Labeling Product Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Non-Radioactive Nucleic Acid Labeling Product Market Facts & Figures by Country
3.3.1 North America Non-Radioactive Nucleic Acid Labeling Product Sales by Country
3.3.2 North America Non-Radioactive Nucleic Acid Labeling Product Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-Radioactive Nucleic Acid Labeling Product Market Facts & Figures by Country
3.4.1 Europe Non-Radioactive Nucleic Acid Labeling Product Sales by Country
3.4.2 Europe Non-Radioactive Nucleic Acid Labeling Product Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Market Facts & Figures by Region
3.5.1 Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Sales by Region
3.5.2 Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Non-Radioactive Nucleic Acid Labeling Product Market Facts & Figures by Country
3.6.1 Latin America Non-Radioactive Nucleic Acid Labeling Product Sales by Country
3.6.2 Latin America Non-Radioactive Nucleic Acid Labeling Product Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Sales by Country
3.7.2 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Non-Radioactive Nucleic Acid Labeling Product Historic Market Analysis by Type
4.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Type (2016-2021)
4.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Type (2016-2021)
4.3 Global Non-Radioactive Nucleic Acid Labeling Product Price by Type (2016-2021)
5 Global Non-Radioactive Nucleic Acid Labeling Product Historic Market Analysis by Application
5.1 Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Application (2016-2021)
5.2 Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Application (2016-2021)
5.3 Global Non-Radioactive Nucleic Acid Labeling Product Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Roche Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Promega
6.3.1 Promega Corporation Information
6.3.2 Promega Description and Business Overview
6.3.3 Promega Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Promega Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.3.5 Promega Recent Developments/Updates
6.4 PerkinElmer
6.4.1 PerkinElmer Corporation Information
6.4.2 PerkinElmer Description and Business Overview
6.4.3 PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2016-2021)
6.4.4 PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.4.5 PerkinElmer Recent Developments/Updates
6.5 Agilent Technologies
6.5.1 Agilent Technologies Corporation Information
6.5.2 Agilent Technologies Description and Business Overview
6.5.3 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.5.5 Agilent Technologies Recent Developments/Updates
6.6 General Electric
6.6.1 General Electric Corporation Information
6.6.2 General Electric Description and Business Overview
6.6.3 General Electric Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2016-2021)
6.6.4 General Electric Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.6.5 General Electric Recent Developments/Updates
6.7 Enzo Biochem
6.6.1 Enzo Biochem Corporation Information
6.6.2 Enzo Biochem Description and Business Overview
6.6.3 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.7.5 Enzo Biochem Recent Developments/Updates
6.8 Merck KGaA
6.8.1 Merck KGaA Corporation Information
6.8.2 Merck KGaA Description and Business Overview
6.8.3 Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.8.5 Merck KGaA Recent Developments/Updates
6.9 Vector Labs
6.9.1 Vector Labs Corporation Information
6.9.2 Vector Labs Description and Business Overview
6.9.3 Vector Labs Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Vector Labs Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.9.5 Vector Labs Recent Developments/Updates
6.10 New England Biolabs
6.10.1 New England Biolabs Corporation Information
6.10.2 New England Biolabs Description and Business Overview
6.10.3 New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Sales, Revenue and Gross Margin (2016-2021)
6.10.4 New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Product Portfolio
6.10.5 New England Biolabs Recent Developments/Updates
7 Non-Radioactive Nucleic Acid Labeling Product Manufacturing Cost Analysis
7.1 Non-Radioactive Nucleic Acid Labeling Product Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-Radioactive Nucleic Acid Labeling Product
7.4 Non-Radioactive Nucleic Acid Labeling Product Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-Radioactive Nucleic Acid Labeling Product Distributors List
8.3 Non-Radioactive Nucleic Acid Labeling Product Customers
9 Non-Radioactive Nucleic Acid Labeling Product Market Dynamics
9.1 Non-Radioactive Nucleic Acid Labeling Product Industry Trends
9.2 Non-Radioactive Nucleic Acid Labeling Product Growth Drivers
9.3 Non-Radioactive Nucleic Acid Labeling Product Market Challenges
9.4 Non-Radioactive Nucleic Acid Labeling Product Market Restraints
10 Global Market Forecast
10.1 Non-Radioactive Nucleic Acid Labeling Product Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-Radioactive Nucleic Acid Labeling Product by Type (2022-2029)
10.1.2 Global Forecasted Revenue of Non-Radioactive Nucleic Acid Labeling Product by Type (2022-2029)
10.2 Non-Radioactive Nucleic Acid Labeling Product Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-Radioactive Nucleic Acid Labeling Product by Application (2022-2029)
10.2.2 Global Forecasted Revenue of Non-Radioactive Nucleic Acid Labeling Product by Application (2022-2029)
10.3 Non-Radioactive Nucleic Acid Labeling Product Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-Radioactive Nucleic Acid Labeling Product by Region (2022-2029)
10.3.2 Global Forecasted Revenue of Non-Radioactive Nucleic Acid Labeling Product by Region (2022-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Non-Radioactive Nucleic Acid Labeling Product Sales (K Units) Growth Rate Comparison by Type (2021-2029)
Table 2. Global Non-Radioactive Nucleic Acid Labeling Product Sales (K Units) Comparison by Application (2021-2029)
Table 3. Global Non-Radioactive Nucleic Acid Labeling Product Market Size by Region (US$ Million) (2016 VS 2021 VS 2029)
Table 4. Key Manufacturers Non-Radioactive Nucleic Acid Labeling Product Covered in This Study
Table 5. Global Non-Radioactive Nucleic Acid Labeling Product Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Non-Radioactive Nucleic Acid Labeling Product Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Non-Radioactive Nucleic Acid Labeling Product Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Non-Radioactive Nucleic Acid Labeling Product Manufacturing Sites and Area Served
Table 11. Manufacturers Non-Radioactive Nucleic Acid Labeling Product Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-Radioactive Nucleic Acid Labeling Product by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Radioactive Nucleic Acid Labeling Product as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non-Radioactive Nucleic Acid Labeling Product Sales by Region (2016-2021) & (K Units)
Table 16. Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Region (2016-2021)
Table 17. Global Non-Radioactive Nucleic Acid Labeling Product Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2016-2021) & (K Units)
Table 19. North America Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Country (2016-2021)
Table 20. North America Non-Radioactive Nucleic Acid Labeling Product Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Country (2016-2021)
Table 22. Europe Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2016-2021) & (K Units)
Table 23. Europe Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Country (2016-2021)
Table 24. Europe Non-Radioactive Nucleic Acid Labeling Product Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Region (2016-2021)
Table 30. Latin America Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Country (2016-2021)
Table 32. Latin America Non-Radioactive Nucleic Acid Labeling Product Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Country (2016-2021)
Table 38. Global Non-Radioactive Nucleic Acid Labeling Product Sales (K Units) by Type (2016-2021)
Table 39. Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Type (2016-2021)
Table 40. Global Non-Radioactive Nucleic Acid Labeling Product Revenue (Million US$) by Type (2016-2021)
Table 41. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Share by Type (2016-2021)
Table 42. Global Non-Radioactive Nucleic Acid Labeling Product Price (USD/Unit) by Type (2016-2021)
Table 43. Global Non-Radioactive Nucleic Acid Labeling Product Sales (K Units) by Application (2016-2021)
Table 44. Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Application (2016-2021)
Table 45. Global Non-Radioactive Nucleic Acid Labeling Product Revenue (Million US$) by Application (2016-2021)
Table 46. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Share by Application (2016-2021)
Table 47. Global Non-Radioactive Nucleic Acid Labeling Product Price (USD/Unit) by Application (2016-2021)
Table 48. Thermo Fisher Scientific Corporation Information
Table 49. Thermo Fisher Scientific Description and Business Overview
Table 50. Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Product
Table 52. Thermo Fisher Scientific Recent Developments/Updates
Table 53. Roche Corporation Information
Table 54. Roche Description and Business Overview
Table 55. Roche Non-Radioactive Nucleic Acid Labeling Product Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Roche Non-Radioactive Nucleic Acid Labeling Product Product
Table 57. Roche Recent Developments/Updates
Table 58. Promega Corporation Information
Table 59. Promega Description and Business Overview
Table 60. Promega Non-Radioactive Nucleic Acid Labeling Product Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Promega Non-Radioactive Nucleic Acid Labeling Product Product
Table 62. Promega Recent Developments/Updates
Table 63. PerkinElmer Corporation Information
Table 64. PerkinElmer Description and Business Overview
Table 65. PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Product
Table 67. PerkinElmer Recent Developments/Updates
Table 68. Agilent Technologies Corporation Information
Table 69. Agilent Technologies Description and Business Overview
Table 70. Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Product
Table 72. Agilent Technologies Recent Developments/Updates
Table 73. General Electric Corporation Information
Table 74. General Electric Description and Business Overview
Table 75. General Electric Non-Radioactive Nucleic Acid Labeling Product Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. General Electric Non-Radioactive Nucleic Acid Labeling Product Product
Table 77. General Electric Recent Developments/Updates
Table 78. Enzo Biochem Corporation Information
Table 79. Enzo Biochem Description and Business Overview
Table 80. Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Product
Table 82. Enzo Biochem Recent Developments/Updates
Table 83. Merck KGaA Corporation Information
Table 84. Merck KGaA Description and Business Overview
Table 85. Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Product
Table 87. Merck KGaA Recent Developments/Updates
Table 88. Vector Labs Corporation Information
Table 89. Vector Labs Description and Business Overview
Table 90. Vector Labs Non-Radioactive Nucleic Acid Labeling Product Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Vector Labs Non-Radioactive Nucleic Acid Labeling Product Product
Table 92. Vector Labs Recent Developments/Updates
Table 93. New England Biolabs Corporation Information
Table 94. New England Biolabs Description and Business Overview
Table 95. New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Product
Table 97. New England Biolabs Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Non-Radioactive Nucleic Acid Labeling Product Distributors List
Table 101. Non-Radioactive Nucleic Acid Labeling Product Customers List
Table 102. Non-Radioactive Nucleic Acid Labeling Product Market Trends
Table 103. Non-Radioactive Nucleic Acid Labeling Product Growth Drivers
Table 104. Non-Radioactive Nucleic Acid Labeling Product Market Challenges
Table 105. Non-Radioactive Nucleic Acid Labeling Product Market Restraints
Table 106. Global Non-Radioactive Nucleic Acid Labeling Product Sales Forecast by Type (2022-2029) & (K Units)
Table 107. Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share Forecast by Type (2022-2029)
Table 108. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Forecast by Type (2022-2029) & (US$ Million)
Table 109. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share Forecast by Type (2022-2029)
Table 110. Global Non-Radioactive Nucleic Acid Labeling Product Sales Forecast by Application (2022-2029) & (K Units)
Table 111. Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share Forecast by Application (2022-2029)
Table 112. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Forecast by Application (2022-2029) & (US$ Million)
Table 113. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share Forecast by Application (2022-2029)
Table 114. Global Non-Radioactive Nucleic Acid Labeling Product Sales Forecast by Region (2022-2029) & (K Units)
Table 115. Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share Forecast by Region (2022-2029)
Table 116. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Forecast by Region (2022-2029) & (US$ Million)
Table 117. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share Forecast by Region (2022-2029)
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-Radioactive Nucleic Acid Labeling Product
Figure 2. Global Non-Radioactive Nucleic Acid Labeling Product Market Share by Type in 2020 & 2029
Figure 3. Biotin Product Picture
Figure 4. DIG System Product Picture
Figure 5. Fluorescent Product Picture
Figure 6. Others Product Picture
Figure 7. Global Non-Radioactive Nucleic Acid Labeling Product Market Share by Application in 2020 & 2029
Figure 8. DNA Labeling
Figure 9. RNA Labeling
Figure 10. Oligonucleotide Labeling
Figure 11. Global Non-Radioactive Nucleic Acid Labeling Product Revenue, (US$ Million), 2016 VS 2021 VS 2029
Figure 12. Global Non-Radioactive Nucleic Acid Labeling Product Market Size 2016-2029 (US$ Million)
Figure 13. Global Non-Radioactive Nucleic Acid Labeling Product Sales 2016-2029 (K Units)
Figure 14. Global Non-Radioactive Nucleic Acid Labeling Product Market Size Market Share by Region: 2016 VS 20210 VS 2029
Figure 15. Non-Radioactive Nucleic Acid Labeling Product Sales Share by Manufacturers in 2020
Figure 16. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Non-Radioactive Nucleic Acid Labeling Product Players: Market Share by Revenue in 2020
Figure 18. Non-Radioactive Nucleic Acid Labeling Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Region (2016-2021)
Figure 20. Global Non-Radioactive Nucleic Acid Labeling Product Sales Market Share by Region in 2020
Figure 21. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Region (2016-2021)
Figure 22. Global Non-Radioactive Nucleic Acid Labeling Product Revenue Market Share by Region in 2020
Figure 23. U.S. Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Non-Radioactive Nucleic Acid Labeling Product Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Non-Radioactive Nucleic Acid Labeling Product by Type (2016-2021)
Figure 48. Sales Market Share of Non-Radioactive Nucleic Acid Labeling Product by Application (2016-2021)
Figure 49. Sales Market Share of Non-Radioactive Nucleic Acid Labeling Product by Application in 2020
Figure 50. Revenue Share of Non-Radioactive Nucleic Acid Labeling Product by Application (2016-2021)
Figure 51. Revenue Share of Non-Radioactive Nucleic Acid Labeling Product by Application in 2020
Figure 52. Manufacturing Cost Structure of Non-Radioactive Nucleic Acid Labeling Product
Figure 53. Manufacturing Process Analysis of Non-Radioactive Nucleic Acid Labeling Product
Figure 54. Non-Radioactive Nucleic Acid Labeling Product Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
